Zobrazeno 1 - 10
of 466
pro vyhledávání: '"A. N. Malaviya"'
Autor:
Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R
Externí odkaz:
https://doaj.org/article/8afbed8558ee4037a7ddc3fa0f34c61f
Autor:
Anand N Malaviya
Publikováno v:
Indian Journal of Rheumatology, Vol 15, Iss 5, Pp 2-5 (2020)
Spondyloarthritis (SpA) is a family of systemic inflammatory rheumatic diseases that have been extensively reported and studied from India over the last >4 decades. The epidemiological studies estimate the prevalence of SpA to be 7–9 per 10,000 per
Externí odkaz:
https://doaj.org/article/5da9bc58cdb2492b8d1503d3befeb478
Publikováno v:
Materials Today: Proceedings. 77:794-804
Autor:
Anand N Malaviya, Sanjiv Kapoor
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 3, Pp 186-194 (2018)
In a landmark breakthrough in 1976, Reichlin and Mattioli discovered the first myositis-specific antibody (MSA) called anti-Mi2 antibody that identified a specific clinical phenotype characterized by pathognomonic skin rash of dermatomyositis, typica
Externí odkaz:
https://doaj.org/article/4397fc74478141cbb74b7b3e2157638e
Autor:
Anand N Malaviya, Ravita Thakaran, Roopa Rawat, Sanjiv Kapoor, Shriram Garg, Sadhana S Baghel, Christy Messi, Vivekanand, Qamar Zaheer
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 4, Pp 233-239 (2018)
Objective: The objective of the study was to study the effectiveness of a recommended screening strategy for latent tuberculosis infection (LTBI) in patients with systemic inflammatory rheumatic diseases (SIRDs) treated with biological disease-modify
Externí odkaz:
https://doaj.org/article/4edd620fb0f14b138f61eb94f0873144
Autor:
Anand N Malaviya
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 2, Pp 240-241 (2021)
Externí odkaz:
https://doaj.org/article/4e03dc5918f943278c8a93d639223f03
Autor:
Anand N. Malaviya, Astha Sareen
Publikováno v:
Indian Journal of Rheumatology.
Publikováno v:
Indian Journal of Rheumatology, Vol 15, Iss 4, Pp 375-375 (2020)
Externí odkaz:
https://doaj.org/article/4d337cd8a1c14621b524443bdc257c17
Publikováno v:
International Journal of Rheumatology, Vol 2017 (2017)
Since 1984 the diagnosis of ankylosing spondylitis (AS) has been based upon the modified New York (mNY) criteria with mandatory presence of radiographic sacroiliitis, without which the diagnosis is not tenable. However, it may take years or decades f
Externí odkaz:
https://doaj.org/article/73b9fc2b07ce4cbcba1fd6d62d266734
Autor:
Sarath Chandra Mouli, Keerthi Talari, Abhrajit Ray, Syamasis Bandyopadhyay, Balebail G. Dharmanand, Anand N. Malaviya, Shankaralingam Rajeshwari, Sanjiv Amin, Sukumar Mukherjee, Pradip Kumar, Pravin Patil, Vinod Ravindran, V K Chaturvedi, Jyotsna Oak
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R